Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAmortization - GoodwillEBIATLeasesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)
Ratios

Maravai Lifesciences Holdings (MRVI) Long-Term Debt Repayments: 2020-2025

Historic Long-Term Debt Repayments for Maravai Lifesciences Holdings (MRVI) over the last 6 years, with Sep 2025 value amounting to $1.4 million.

  • Maravai Lifesciences Holdings' Long-Term Debt Repayments changed negligibly% to $1.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $234.4 million, marking a year-over-year increase of 4208.69%. This contributed to the annual value of $234.4 million for FY2024, which is 4208.69% up from last year.
  • Maravai Lifesciences Holdings' Long-Term Debt Repayments amounted to $1.4 million in Q3 2025, which was down 0.00% from $1.4 million recorded in Q2 2025.
  • In the past 5 years, Maravai Lifesciences Holdings' Long-Term Debt Repayments registered a high of $230.3 million during Q4 2024, and its lowest value of $1.4 million during Q2 2022.
  • In the last 3 years, Maravai Lifesciences Holdings' Long-Term Debt Repayments had a median value of $1.4 million in 2025 and averaged $22.2 million.
  • As far as peak fluctuations go, Maravai Lifesciences Holdings' Long-Term Debt Repayments plummeted by 99.63% in 2021, and later spiked by 16,834.78% in 2024.
  • Over the past 5 years, Maravai Lifesciences Holdings' Long-Term Debt Repayments (Quarterly) stood at $1.5 million in 2021, then fell by 9.33% to $1.4 million in 2022, then remained steady at $1.4 million in 2023, then surged by 16,834.78% to $230.3 million in 2024, then remained steady at $1.4 million in 2025.
  • Its Long-Term Debt Repayments was $1.4 million in Q3 2025, compared to $1.4 million in Q2 2025 and $1.4 million in Q1 2025.